Table. Antimicrobial drug susceptibility and pulsed-field gel electrophoresis (PFGE) patterns of 10 Acinetobacter lwoffii strains, Italy, 2002–2005.
| No. | Source* | Drug† | Antibiotype | PFGE | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AS | PI | PT | CE | CT | CA | CF | AT | CI | LE | OF | GM | TM | AM | TC | IP | MP | TS | ||||
| 1 | ICU | R | R | R | R | R | R | R | R | R | R | R | R | R | S | R | S | S | R | a | A |
| 2 | ICU | R | R | R | R | R | R | R | R | R | R | R | R | R | S | R | S | S | R | a | B |
| 3 | OW | R | R | R | R | R | R | R | R | R | R | R | R | R | S | R | S | S | R | a | B |
| 4 | ICU | R | R | R | R | R | R | R | R | S | R | R | R | R | S | R | S | S | R | b | C |
| 5 | ICU | S | S | R | S | S | R | R | R | R | R | R | S | S | S | S | S | S | S | c | D |
| 6 | ICU | R | S | S | S | R | R | R | S | S | S | S | R | R | S | S | S | S | S | d | E |
| 7 | UW | S | S | S | R | R | R | R | R | S | S | S | S | S | S | R | S | S | S | e | F |
| 8 | ICU | S | R | S | R | R | S | R | R | S | S | S | S | S | S | S | S | S | R | f | G |
| 9 | ICU | S | R | S | R | R | S | R | R | S | S | S | S | S | S | S | S | S | R | f | G |
| 10 | MW | S | S | S | S | S | R | S | R | S | R | R | R | S | R | S | S | S | S | g | H |
*ICU, intensive care unit; OW, orthopedic ward; UW, urologic ward; MW, medical ward. †AS, ampicillin-sulbactam; PI, piperacillin; PT, piperacillin-tazobactam; CE, cefepime; CT, cefotaxime; CA, ceftazidime; CF, ceftriaxone; AT, aztreonam; CI, ciprofloxacin; LE, levofloxacin; OF, ofloxacin; GM, gentamicin; TM, tobramycin; AM, amikacin; TC, tetracycline; IP, imipenem; MP, meropenem; TS, trimethoprim-sulfamethoxazole; R, resistant; S, susceptible.